English
Deutsch
Log In
Log in with Fraunhofer Smartcard
Password Login
Research Outputs
Fundings & Projects
Researchers
Institutes
Statistics
Fraunhofer-Gesellschaft
Home
Fraunhofer-Gesellschaft
Scopus
Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosis
Details
Full
Export
Statistics
Options
Show all metadata (technical view)
2025
Journal Article
Title
Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosis
Author(s)
Castells, Mariana Concepcion
Brigham and Women's Hospital
Akin, Cem
University of Michigan, Ann Arbor
Hartmann, Karin
Universitätsspital Basel
Broesby-Olsen, Sigurd
Odense Universitetshospital
George, Tracy Irene
ARUP Laboratories
Powell, Dakota
Blueprint Medicines Corporation
Bidollari, Ilda
Blueprint Medicines Corporation
Lin, Huimin
Blueprint Medicines Corporation
Lampson, Benjamin
Blueprint Medicines Corporation
Doyle, Ashley
Blueprint Medicines Corporation
Siebenhaar, Frank
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP
Sabato, Vito
Universitair Ziekenhuis Antwerpen
Journal
The journal of allergy and clinical immunology. In practice
Open Access
DOI
10.1016/j.jaip.2025.05.026
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP